Judit Horvath

Title: Innovations of Judit Horvath in Receptor Tyrosine Kinase Inhibitors

Introduction

Judit Horvath is a notable inventor based in Menlo Park, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of receptor tyrosine kinase inhibitors. With a total of 5 patents to her name, her work has had a substantial impact on drug formulation and delivery.

Latest Patents

One of her latest patents focuses on stable and soluble formulations of receptor tyrosine kinase inhibitors, specifically pazopanib. This patent outlines methods of preparation for these formulations and their use in sustained delivery of the active agent to a target site. Additionally, the patent discusses methods for converting one polymorphic form of a TKI to another polymorphic form or an amorphous form. This innovation is crucial for enhancing the efficacy and stability of TKI therapies.

Career Highlights

Judit Horvath is currently associated with Forsight Vision4, Inc., where she continues to advance her research and development efforts. Her expertise in pharmaceutical formulations has positioned her as a key player in the industry, contributing to the ongoing evolution of cancer treatment options.

Collaborations

Judit has collaborated with talented professionals in her field, including Irina Astafieva and Signe R Erickson. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new therapeutic solutions.

Conclusion

Judit Horvath's work in receptor tyrosine kinase inhibitors exemplifies the importance of innovation in the pharmaceutical industry. Her contributions continue to pave the way for advancements in drug formulation and delivery systems.